title: Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation.
authors.affiliation: Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton SO16 7PX, UK.
authors.forename: J
authors.initials: J
authors.lastname: Bryant
authors.forename: C
authors.initials: C
authors.lastname: Cave
authors.forename: B
authors.initials: B
authors.lastname: Mihaylova
authors.forename: D
authors.initials: D
authors.lastname: Chase
authors.forename: L
authors.initials: L
authors.lastname: McIntyre
authors.forename: K
authors.initials: K
authors.lastname: Gerard
authors.forename: R
authors.initials: R
authors.lastname: Milne
mesh_terms: D002648:Child; D003362:Cost-Benefit Analysis; D019382:Human Growth Hormone / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011218:Prader-Willi Syndrome / Q000188:drug therapy; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D013222:State Medicine; D016896:Treatment Outcome; D014424:Turner Syndrome / Q000188:drug therapy; D006113:United Kingdom
chemical_list: D019382:Human Growth Hormone